gpawelski
04-02-2008, 09:30 PM
A drug to treat colon cancer is proving much more convenient than traditional chemotherapy, has fewer side effects - and a study of almost 2,000 patients has shown it is giving them a better chance of surviving the disease.
"Standard chemotherapy can be incredibly disruptive to people's lives," said Prof Professor Chris Twelves of the University of Leeds, who led the research. "Patients visit hospital five days a week for the injections and then have three weeks off before returning to hospital for the next course and the side effects can be unpleasant."
The oral chemotherapy drug Xeloda (capecitabine) offers fewer side-effects and less time in hospital and the trial has shown that patients given the drug were at least as likely to be alive and free of their disease as those on standard chemotherapy (the Mayo Clinic regimen).
http://www.cancerfocus.net/node/627
"Standard chemotherapy can be incredibly disruptive to people's lives," said Prof Professor Chris Twelves of the University of Leeds, who led the research. "Patients visit hospital five days a week for the injections and then have three weeks off before returning to hospital for the next course and the side effects can be unpleasant."
The oral chemotherapy drug Xeloda (capecitabine) offers fewer side-effects and less time in hospital and the trial has shown that patients given the drug were at least as likely to be alive and free of their disease as those on standard chemotherapy (the Mayo Clinic regimen).
http://www.cancerfocus.net/node/627